Effectiveness and safety of ledipasvir and sofosbuvir for patients infected with HCV genotype 1 in clinical practices
Not Applicable
- Conditions
- Chronic hepatitis C genotype 1
- Registration Number
- JPRN-UMIN000024007
- Lead Sponsor
- Kyushu University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 1000
Inclusion Criteria
Not provided
Exclusion Criteria
(1)Decompensated cirrhosis (Child B/C) (2)Autoimmune hepatitis or primary biliary cholangiris (3)eGFR<30 (4)Positivity for antibody to HIV
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Rates of Sustained virological response at 12 weeks after the end of treatment
- Secondary Outcome Measures
Name Time Method